William D. Carlson
Corporate Officer/Principal bij Harvard Medical School
Actieve functies van William D. Carlson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Loopbaan van William D. Carlson
Eerdere bekende functies van William D. Carlson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARQULE, INC. | Oprichter | - | - |
| Smith Kline & French BV | Corporate Officer/Principal | - | - |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | 01-01-2003 | 09-05-2013 |
| Oprichter | 01-01-2003 | - |
Opleiding van William D. Carlson
| Yale University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Nederland | 2 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
| Smith Kline & French BV | |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
- Beurs
- Insiders
- William D. Carlson
- Ervaring
